Vimarsana
Biggest News Aggregation in the World

Page 16 - Dan Budwick News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dan Budwick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dan Budwick Today - Breaking & Trending Today

Gritstone bio Announces Inducement Grants Under Nasdaq - Vimarsana News

Gritstone bio Announces Inducement Grants Under Nasdaq

EMERYVILLE, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop...

Singular Genomics to Present at the Gilmartin Group Emerging Growth Company Showcase - Vimarsana News

Singular Genomics to Present at the Gilmartin Group Emerging Growth Company Showcase

SAN DIEGO, Sept. 08, 2023 -- Singular Genomics Systems, Inc. , a company leveraging novel next-generation sequencing and multiomics technologies to empower researchers and clinicians, today...

Beam Therapeutics Presents Preclinical Data Highlighting Utility of BEAM-302 to Correct an Alpha-1 Antitrypsin (AAT) Deficiency Disease-Causing Mutation - Vimarsana News

Beam Therapeutics Presents Preclinical Data Highlighting Utility of BEAM-302 to Correct an Alpha-1 Antitrypsin (AAT) Deficiency Disease-Causing Mutation

First Preclinical Data for BEAM-302 Demonstrate Increased Levels of Corrected AAT and Reduced Mutant PiZ AAT in Multiple In Vivo Rodent Disease ModelsCAMBRIDGE, Mass., Sept. 07, 2023 -- Beam...

Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL - Vimarsana News

Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL

BEAM-201 Represents First Quadruplex-edited, Allogeneic CAR-T Cell Therapy Candidate in Clinical-stage Development and First Treatment with a Base Editing Candidate in United States CAMBRIDGE,...

Alector to Participate in Upcoming Healthcare Conferences - Vimarsana News

Alector to Participate in Upcoming Healthcare Conferences

SOUTH SAN FRANCISCO, Calif., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in the following upcoming investor conferences: Morgan Stanley 21st Annual Global Healthcare Conference (New York, New York) Monday, September 11, 2023 at 4:55 p.m. ET, fireside chat H.C. Wainwright 25th Annual Global Investment Conference (New York, New York) Tuesday, September 12, 2023 a

Source: yahoo.com